Image de couverture de livre

Expanding the Impact of New Cystic Fibrosis Therapies in Low‐ and Middle‐Income Countries

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteur principal:	Eitan Kerem
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	Pediatric Pulmonology
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Sleep‐Disordered Breathing in Cystic Fibrosis in Low‐ and Middle‐Income Countries
par: Merve Selçuk Balcı, et autres
Publié: (2026)

Advancing Mental Healthcare for Individuals With Cystic Fibrosis in Low‐ and Middle‐Income Countries
par: Alexandra L. Quittner, et autres
Publié: (2026)

Global Collaboration in Cystic Fibrosis: Lessons From the COVID‐19 Pandemic for Low‐ and Middle‐Income Countries
par: Stephanie Y. Cheng, et autres
Publié: (2026)

Disparities in Access to Cystic Fibrosis Therapy Across Countries
par: Bulent Karadag
Publié: (2026)

Expanding Cystic Fibrosis Registries to the Rest of the World
par: Lutz Naehrlich
Publié: (2026)

Thoracotomies in Children in Low to Middle Income Countries: The Indications for Surgery
par: Jacobus Botha, et autres
Publié: (2025)

Building a global community in pediatric pulmonology—insights from the INSPiRED Congress
par: Eitan Kerem, et autres
Publié: (2025)

Challenges and Practical Solutions in the Management of Cystic Fibrosis in Resource‐Limited Countries: The Indian Experience
par: Grace R. Paul, et autres
Publié: (2026)

The Impact of Cystic Fibrosis‐Related Diabetes on Barriers to Self‐Management
par: Rebecca J. Vitale, et autres
Publié: (2026)

Implementation of Cystic Fibrosis Responsibility, Independence, Self‐Care, Education Program Enhances Cystic Fibrosis Knowledge in Limited Resource Country: Results From a Randomized Controlled Trial
par: Merve Selcuk Balcı, et autres
Publié: (2025)

Domain‐Specific Olfaction in Children and Adults in the Era of Modulator Therapy for Cystic Fibrosis
par: Jeremy P. Tervo, et autres
Publié: (2025)

Prevalence and Distribution of Musculoskeletal Symptoms in Cystic Fibrosis and Impacts on Daily Life
par: Elizabeth Clarke, et autres
Publié: (2024)

Impact of Elexacaftor‐Tezacaftor‐Ivacaftor on Quality of Life in Children With Cystic Fibrosis
par: Sara Kümmerli, et autres
Publié: (2026)

Pathophysiology of Cystic Fibrosis Liver Disease
par: Vania L. Kasper, et autres
Publié: (2024)

Roadmap to Global Cystic Fibrosis Care
par: Samya Z. Nasr, et autres
Publié: (2025)

Cystic Fibrosis Year in Review 2024
par: Adrienne P. Savant
Publié: (2025)

Impact of Modulator Therapy on the Chronic Colonization of Lower Respiratory Tract Pathogens in Children: Data From Cystic Fibrosis Registry of Turkey
par: Birce Sunman, et autres
Publié: (2025)

Impact of Elexacaftor/Tezacaftor/Ivacaftor on Microbiology and Antibiotic Utilization in People With Cystic Fibrosis
par: Cindy L. Williams, et autres
Publié: (2025)

Impact of Elexacaftor/Tezacaftor/Ivacaftor on Fecal Elastase‐1 in Children With Cystic Fibrosis
par: Senthilkumar Sankararaman, et autres
Publié: (2025)

Systematic Review of Nasal Endoscopy Scores in Cystic Fibrosis Patients Treated With Cystic Fibrosis Transmembrane Conductance Regulator Modulators
par: Rebecca Gallardo, et autres
Publié: (2026)

Impact of Number of Pharmacies on Dornase Alfa Medication Possession Ratio in Children With Cystic Fibrosis
par: Rebecca S. Pettit, et autres
Publié: (2025)

Mental Health of Pediatric Patients with Cystic Fibrosis after 18 Months on Elexacaftor‐Tezacaftor‐Ivacaftor Therapy
par: Kimberly Pasley, et autres
Publié: (2024)

Assessing Dietary Patterns and Composition Among Adults With Cystic Fibrosis Taking Highly Effective Modulator Therapy
par: Julianna Bailey, et autres
Publié: (2026)

“No Words for Feelings”: Alexithymia in Children With Cystic Fibrosis and Their Caregivers
par: Tuğba Şişmanlar Eyüboğlu, et autres
Publié: (2026)

The Impact of Attention Deficit Hyperactivity Disorder on Home Spirometry and Other Parameters in People With Cystic Fibrosis
par: Aqeem Azam, et autres
Publié: (2025)

Transforming Care in Cystic Fibrosis: The Long‐Term Impact of Quality Improvement Projects on Clinical Outcomes
par: S. Karabulut, et autres
Publié: (2026)

Impact of Home Collection and Shipping of Respiratory Specimens on Bacterial Pathogen Detection in Children With Cystic Fibrosis
par: Jordana E. Hoppe, et autres
Publié: (2025)

E‐Cigarettes and Cystic Fibrosis—Current Perceptions and Future Directions
par: Maryam Sahibqran, et autres
Publié: (2024)

Case Report: Alpha‐Gal Diagnosis in an Adolescent With Cystic Fibrosis
par: Sean Coyne, et autres
Publié: (2024)

Tobramycin Pharmacokinetics in Pediatric People With Cystic Fibrosis on Maintenance Azithromycin
par: Chelsea Flora, et autres
Publié: (2026)

Hospitalizations in Infants and Young Children With Cystic Fibrosis Enrolled in Medicaid
par: Laurie P. Murray, et autres
Publié: (2025)

Fueling Health: Overcoming Food Barriers in Cystic Fibrosis Care
par: Brittany A. Wright, et autres
Publié: (2025)

Current State of Pharmacogenomic Implementation Into Care for Persons With Cystic Fibrosis
par: Emma M. Tillman, et autres
Publié: (2025)

Patient‐Derived Intestinal Organoids in the Global Cystic Fibrosis Landscape
par: Suzanne Kroes, et autres
Publié: (2026)

Commentary on “Impact of Home Collection and Shipping of Respiratory Specimens on Bacterial Pathogen Detection in Children With Cystic Fibrosis”
par: Ahmet Kağan Özkaya, et autres
Publié: (2025)

Real‐World Impact of Elexacaftor/Tezacaftor/Ivacaftor in Israeli Children Aged 2–6 With Cystic Fibrosis
par: Adi Dagan, et autres
Publié: (2026)

The Impact of Elexacaftor‐Tezacaftor‐Ivacaftor on Biochemical Surrogates of Cystic Fibrosis Hepatobiliary Involvement: A Retrospective Cohort Study
par: Sasha‐Jane Abi‐Aad, et autres
Publié: (2026)

Current Status and the Need for CFTR Modulator Therapy in Cystic Fibrosis Patients in Mainland China: A Case Report and Literature Review
par: Yuxiao Sun, et autres
Publié: (2026)

Linaclotide Use for the Treatment of Constipation and Gastrointestinal Symptoms in People With Cystic Fibrosis
par: Lauren N. Kormelink, et autres
Publié: (2024)

Facilitators and Barriers to Increasing Equity in Cystic Fibrosis Newborn Screening Algorithms
par: Kellyn Madden, et autres
Publié: (2024)